About Shandong Jincheng Pharmaceutical Group Co., Ltd. was established in 2004, and is headquartered in Zibo City, Shandong Province. In 2011, Jincheng Pharma was listed on GEM of Shenzhen Stock Exchange (Stock code SZ300233). Now it is a National High-tech Enterprise with more than 3800 employees and more than 30 participating holding companies around the world (including Italy, Beijing, Shanghai, Hangzhou, Zhongshan). Jincheng Pharma mainly engaged in the R&D, production and marketing of pharmaceutical intermediates, APIs, finished pharmaceutical products, and general health products, which is the world's largest production and research base of cephalosporins side-chain intermediates and bio-fermentation API Glutathione, domestic well-known manufacturer of anti-infection and gynecological preparations, and has the most abundant cephalosporin antibiotics and gynecology full-life-cycle series products in China. The company is a burgeoning entire-industry-chain innovative pharmaceutical and health industry group, with international layout and integrating research, manufacturing and marketing.
The company adheres to the strategic development orientation of basing on "general medicine" and expanding "general health", and focuses on products for the therapeutic areas of anti-infection, gynecology, antiviral, chronic disease, pediatrics, hormone and immune regulation, liver disease. We provide more than 80 pharmaceutical products, such as APIs, injections, tablets, capsules, soft capsules, powders, sprays, creams, etc., based on ten manufacturing sites in “Beijing, Shanghai, Guangzhou and Shandong Province”. It has created many famous brand products in the industry, such as Jincheng cephalosporin intermediate, Golden quality antibiotic series, Langyi gynecology series, Glutathione API and health care product series. There are 2 sterile powder injections won the bid for the national centralized procurement of drugs, more than 10 products passed the consistency evaluation.
The company has established long-term cooperative relationships with hundreds of pharmaceutical companies around the world, and has formed a global market layout with the domestic market as the main body, Europe, America and India market as the leading exporters, and extending to the markets of Japan, South Korea and ASEAN. We provide pharmaceutical products and health products for more than 30 countries and regions, and more than 3000 domestic medical institutions and chain drugstores, bring health to hundreds of millions of patients every year.
Relying on years of accumulation in technology, talents, and industrialization, the company has formed multiple core competitiveness in technology and management innovation, such as safe and green environmental protection technology, quality management, cost control, and lean management. It has a R&D team of more than 200 people, led by Taishan industry leading talent, focusing on chemical synthesis, synthetic biology and finished pharmaceutical products, etc., and has built 3 National-level Scientific Research Platforms, 5 Provincial-level Scientific Research Platforms, and 6 Provincial-level Enterprise Technology Centers. There are 3 manufacturing sites for cephalosporin pharmaceutical intermediates, 2 manufacturing sites for chemical APIs, 2 manufacturing sites for biosynthetic APIs, and 3 manufacturing sites for finished pharmaceutical products. The sites of finished pharmaceutical products have 13 biopharmaceutical production lines such as automatic fermentation, separation and purification, sterile separation packed powder injection, and 13 pharmaceutical products production lines such as powder, capsules, tablets, cream, granules, and sterile powder injections. The company has won more than 300 honors such as the National Science and Technology Progress prize and the Best GEM Listed Company, and has been successfully selected into the FTSE Russell index, ranked among the " Double top 100" of China's medical industry and China's pharmaceutical industry, and is making great strides towards the development vision of "Becoming an innovative leading enterprise in the pharmaceutical and health industry".
The company is committed to the overall strategy of "Focus on main business; Pursue resource integration; Focus on innovation". In the future, we will continue to aim at high-quality development, with the goal of meeting customer and clinical needs, focus on high-end pharmaceutical and chemical products, high-threshold characteristic APIs and bioactive products, high-level generic drugs and improved new drugs. At the same time, the company is committed to expanding CMO/CDMO business, actively exploring the field of new drugs, improving the innovation system of the entire-industry-chain, developing new models of pharmaceutical R&D, and striving to build the company into a world-renowned and nationally leading innovative pharmaceutical and health industry group.
Shandong jincheng pharmaceutical group co., LTD., with excellent product quality, service and trusted by the masses of customers at home and abroad, the company always adhere to the "customer satisfaction is one of the biggest satisfaction" business philosophy, constantly on the new innovation, product sales throughout the domestic each big pharmaceutical companies, and exported to Europe and Asia, and other dozens of countries and regions, is deep the customer trust and praise.
★ Key high-tech enterprises under the national torch program
★ National postdoctoral research station
★ The state recognizes the enterprise technology center
★ The country's 100 most respected listed companies by investors
★ Best gem listed companies
★ Second Prize of National Award for Science and Technology Process
★ First Prize of China Petroleum and Chemical Industry Association Award
★ Enterprise technical centre of Shandong Province
★ The Engineering and Technology Research Center of Cephalosporin intermediates of Shandong Province
★ Provincial Industry technology innovation strategic alliance of cephalosporin intermediates
★ Academician workstation of Shandong Province
★ Abide Contract and Regard for Credit Enterprise of Shandong Province
★ The patent star enterprise of Shandong Province
★ Excellent Enterprise of Shandong Province for Management Innovation
★ The products of Ceftazidime and Cefixime has been listed in the “National Key New Products”
★ MAEM、SMIA has been listed in the “National Torch Plan”
★ First Prize of Provincial award of science and technology process
Jincheng medical enterprise logo interpretation
The logo is designed with JC, the first letter of jincheng. Through the description of the model, it achieves very good uniqueness and perfect recognition.
Marks the overall orderly formation of a molecular structure, appropriate industry attributes; Around different line finally collected up three lines, meaning the company image of strict and orderly management and team cohesion, up three lines of the dark, the jincheng medical efforts to move forward at a speed of stiffness and strong, and the part of the baseline pinto, shows the development of my company massiness, solid pace; Use turquoise, borrowing the color of the logo of blue power of science and technology, business and calm attitude of doing things, to reflect enterprise green environmental protection and health concept, marked overall concise, atmospheric, recognition.
Shandong jincheng pharmaceutical group co., LTD is a young and energetic enterprise. Since its establishment, the company adhere to the "big health and medicine, make with characteristic of jincheng pharmaceutical industry chain" industry positioning, focusing on "cephalosporin antibiotics terminal industry chain, polypeptide characteristic biological pharmaceutical industry chain, and regulating immune preparation characteristics of department of gynaecology pharmaceutical industry chain" three major direction of research and development, production and sales, make science and technology, management and culture based on the three core competitiveness, adhere to the combination of scale expansion and standard operation, realized the high speed, the healthy growth of the enterprise.
Over the years, we always adhere to the "unity, dedication, truth-seeking, innovative" spirit of enterprise, adhering to the "booster medicine progress, and enjoy a healthy life" of the enterprise mission, adhere to the "integrity, openness, innovation, competition and win-win" core values, the pursuit of "innovative medical healthy industry leading enterprise" the vision of goals. We firmly believe that: excellent enterprise with excellent enterprise culture and source for gene, with scientific, fair and competitive enterprise management mechanism for bone and main and collateral channels, more with a good team for the soul and rely on! We adhere to the "gathering strength, Shared growth" concept of development, around the goal of enterprise and staff growing together, actively advocate "innovation culture, team culture, competition, performance culture, Shared culture", with the constant development of enterprise at the same time, the more the cultural promotion, perfect mechanism and the growth of the team.
Since the company went public in 2011, greatly expanded the company's development space, enrich the connotation of the development of the company, to further consolidate the company's industry position, sustainable development has a crucial influence to the future of jincheng pharmaceutical, become a new point of departure for company future development to take off. We will take this opportunity to further integration of resources, gathering strength, Shared growth, positive practice product, technology and management innovation, striving for scientific, standard and harmonious development, for the development of Chinese medicine industry contributes an own strength, for employees, shareholders and society to create greater value!
Golden city medicine is still on the way. I believe that everyone has a jincheng pharmaceutical ready, let us join hands and with our faith, the pursuit and dedication to open new voyage, skip over the waves, go forward, the common practice of "jincheng" brand industry took off the second dream, efforts to the company into a "science and technology, ecology, standardization, branding and internationalization" of the modern medical health industry innovation leader.
Beijing jincheng fanglue medical technology co. LTD
Beijing longyi pharmaceutical co. LTD
Shandong jincheng kerui chemical co. LTD
Shandong huihai pharmaceutical chemical co. LTD
Shandong jincheng bio-pharmaceutical co. LTD
Shanghai jincheng pharmaceutical co. LTD
Guangdong jincheng jinsu pharmaceutical co. LTD
Shandong jincheng graphene technology co. LTD